Mereo BioPharma Group plc, a biopharmaceutical company, develops and commercializes therapeutics for the treatment of rare diseases in the United Kingdom and the United States. The company develops Setrusumab, an antibody for the treatment ...
Q1 2026
May 12, 2026
FY 2025
Mar 19, 2026
Q4 2025
Q3 2025
Nov 10, 2025
Q2 2025
Aug 12, 2025